Os doentes receberam os cuidados médicos através dos serviços da Veterans Health Administration. As atividades específicas de acompanhamento baseadas em farmacêuticos estiveram associadas a maior adesão dos doentes ao dabigatrano.
Referências
- Shore S, Ho M, Lambert-Kerzner A, et al. Site-level variation in and practices associated with dabigatran adherence.JAMA 2015; 313:1443-1450. Abstract
- Shore S, Carey EP, Turakhia MP, et al. Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration. Am Heart J 2014; 167:810-817. Abstract
- Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med2011; 365:883-891. Article
- Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med2013; 369:2093-2104. Article
